SCHEMBL4186552

SCHEMBL4186552

CC(CC1CCN(C(=O)OC(C)(C)C)CC1)NCc1ccccc1NC(=O)c1cccs1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
MAPT P10636 3/20 0.46
POLB P06746 1/20 0.46
KDM4E B2RXH2 2/20 0.44
PKM P14618 1/20 0.44
GPR119 Q8TDV5 3/20 0.42
TSHR P16473 2/20 0.41
LMNA P02545 2/20 0.41
MAPK1 P28482 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HSD17B10 Q99714 1/20 0.40
CHRM2 P08172 1/20 0.40
CHRM5 P08912 1/20 0.40
CHRM3 P20309 1/20 0.40
TGFBR1 P36897 3/20 0.39
BCHE P06276 1/20 0.39
APLNR P35414 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14343745 0.88 ALDH1A1 (0.51) ALDH1A1MAPTPOLBTSHRLMNA
SCHEMBL4193494 0.84 KDM4E (0.49) ALDH1A1KDM4EPKMGPR119TGFBR1
SCHEMBL4189918 0.84 ALDH1A1 (0.57) ALDH1A1MAPTPOLBKDM4ETSHR
SCHEMBL4191134 0.83 MEN1 (0.47) ALDH1A1MAPTKDM4EPKMGPR119
SCHEMBL4188002 0.83 ALDH1A1 (0.56) ALDH1A1MAPTPOLBKDM4ETSHR
SCHEMBL14344009 0.83 ALDH1A1 (0.56) ALDH1A1MAPTPOLBKDM4ETSHR
Hydrochloric Acid SCHEMBL4202482 0.82 ALDH1A1 (0.55) ALDH1A1MAPTPOLBKDM4ETSHR
SCHEMBL4707714 0.81 MAPT (0.54) ALDH1A1MAPTPOLBKDM4ETSHR
SCHEMBL4203983 0.81 GPR119 (0.41) MAPTKDM4EPKMGPR119TGFBR1
SCHEMBL20601364 0.76 KDM4E (0.52) ALDH1A1MAPTPOLBKDM4EPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed
EP-1879877-A2 ANTIMICROBIAL AGENTS Ranbaxy Laboratories Limited (IN) 2008-01-23 EP disclosed
WO-2006117762-A2 ANTIMICROBIAL AGENTS RANBAXY LABORATORIES LIMITED (IN) 2006-11-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 ALDH1A1 2744/4885MAPT 2269/4885POLB 215/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.